NDC 16729-045-01 - ATORVASTATIN CALCIUM
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 16729-045
- Requested NDC
- 16729-045-01
- Package NDCs from labels
- 16729-045-10, 16729-045-15, 16729-045-01, 16729-045-16, 16729-045-17
- Manufacturer
- Accord Healthcare Inc. | Intas Pharmaceuticals Limited
- Effective date
- 2025-10-06
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| ATORVASTATIN CALCIUM - Accord Healthcare Inc. | Intas Pharmaceuticals Limited | Accord Healthcare Inc. | Intas Pharmaceuticals Limited | 2025-10-06 | HUMAN PRESCRIPTION DRUG LABEL |
| ATORVASTATIN CALCIUM - Bryant Ranch Prepack | Bryant Ranch Prepack | 2024-10-31 | HUMAN PRESCRIPTION DRUG LABEL |
| ATORVASTATIN CALCIUM - NuCare Pharmaceuticals,Inc. | NuCare Pharmaceuticals,Inc. | 2024-06-20 | HUMAN PRESCRIPTION DRUG LABEL |
| ATORVASTATIN CALCIUM - REMEDYREPACK INC. | REMEDYREPACK INC. | 2024-02-23 | HUMAN PRESCRIPTION DRUG LABEL |
| ATORVASTATIN CALCIUM - RPK Pharmaceuticals, Inc. | RPK Pharmaceuticals, Inc. | 2023-06-07 | HUMAN PRESCRIPTION DRUG LABEL |
| ATORVASTATIN CALCIUM - Preferred Pharmaceuticals Inc. | Preferred Pharmaceuticals Inc. | 2023-03-31 | HUMAN PRESCRIPTION DRUG LABEL |
| ATORVASTATIN CALCIUM - Denton Pharma, Inc. DBA Northwind Pharmaceuticals | Denton Pharma, Inc. DBA Northwind Pharmaceuticals | 2023-01-03 | HUMAN PRESCRIPTION DRUG LABEL |
| ATORVASTATIN CALCIUM - Proficient Rx LP | Proficient Rx LP | 2022-04-01 | HUMAN PRESCRIPTION DRUG LABEL |
| ATORVASTATIN CALCIUM - Quality Care Products, LLC | Quality Care Products, LLC | 2021-09-22 | HUMAN PRESCRIPTION DRUG LABEL |
| ATORVASTATIN CALCIUM - NuCare Pharmaceuticals,Inc. | NuCare Pharmaceuticals,Inc. | 2021-06-08 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 16729-045-01 | ATORVASTATIN CALCIUM | 100 in 1 BOTTLE | TABLET, FILM COATED | 100 | 13 | |
| 16729-045-10 | ATORVASTATIN CALCIUM | 30 in 1 BOTTLE | TABLET, FILM COATED | 30 | 13 | |
| 16729-045-15 | ATORVASTATIN CALCIUM | 90 in 1 BOTTLE | TABLET, FILM COATED | 90 | 13 | |
| 16729-045-16 | ATORVASTATIN CALCIUM | 500 in 1 BOTTLE | TABLET, FILM COATED | 500 | 13 | |
| 16729-045-17 | ATORVASTATIN CALCIUM | 1000 in 1 BOTTLE | TABLET, FILM COATED | 1000 | 13 |
DailyMed Dashboard NDC Coverage#
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 16729-045-15 | EA - Each | 16729-045 | ec800b59-eb53-4816-ab9d-7ff42a9cb5ef | 1 | 2021-06-02 |
| 16729-045-17 | EA - Each | 16729-045 | d79f8df8-c45e-4468-97c7-9884a2fcd530 | 1 | 2018-08-13 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.